SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-22-005592
Filing Date
2022-08-11
Accepted
2022-08-11 07:00:30
Documents
6
Period of Report
2022-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_081122.htm 6-K 7991
2 EXHIBIT 99.1 exh_991.htm EX-99.1 391308
3 EXHIBIT 99.2 exh_992.htm EX-99.2 240140
4 EXHIBIT 99.3 exh_993.htm EX-99.3 8739
5 EXHIBIT 99.4 exh_994.htm EX-99.4 8532
6 GRAPHIC logo.jpg GRAPHIC 6524
  Complete submission text file 0001171843-22-005592.txt   666826
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40858 | Film No.: 221153603
SIC: 2834 Pharmaceutical Preparations